FVLZX
Price
$43.21
Change
+$0.01 (+0.02%)
Updated
Jun 22 closing price
Net Assets
384.49M
MVCAX
Price
$33.35
Change
+$0.21 (+0.63%)
Updated
Jun 22 closing price
Net Assets
17B
Interact to see
Advertisement

FVLZX vs MVCAX

FVLZX vs MVCAX Comparison Chart in %
View a ticker or compare two or three
VS
FVLZX vs. MVCAX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FVLZX is a Hold and MVCAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17B vs. FVLZX (384M). MVCAX (1.16) and FVLZX (1.14) have matching dividends . FVLZX was incepted earlier than MVCAX: FVLZX (9 years) vs MVCAX (25 years). MVCAX (0.98) is less costly to investors than FVLZX (0.68). FVLZX is a more actively managed with annual turnover of: 68.00 vs. MVCAX (24.00). FVLZX has a lower initial minimum investment than MVCAX: FVLZX (0) vs MVCAX (1000). FVLZX annual gain was more profitable for investors over the last year : 27.99 vs. MVCAX (11.29). FVLZX return over 5 years is better than : 39.56 vs. MVCAX (14.75).
FVLZXMVCAXFVLZX / MVCAX
Total Expense Ratio0.680.9770%
Annual Report Gross Expense Ratio0.680.9869%
Fund Existence9 years25 years-
Gain YTD19.80010.210194%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets384M17B2%
Annual Yield % from dividends1.141.1699%
Returns for 1 year27.9911.29248%
Returns for 3 years46.3223.67196%
Returns for 5 years39.5614.75268%
Returns for 10 yearsN/A87.51-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCRX9.140.15
+1.67%
BioCryst Pharmaceuticals
UDR37.740.18
+0.48%
UDR
IPI34.38-0.11
-0.32%
Intrepid Potash
HOVNP20.38-0.12
-0.61%
Hovnanian Enterprises
DOMH3.19-0.17
-5.19%
Dominari Holdings